CLNN Clene Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 14, 2026
$4,08
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$3,2552 haftanın en düşüğü
$13,5052 haftanın en yükseği
Piyasa Değeri (MRQ)
$52M
Gelir
$200.0K
rozetleriniz
52 Haftlık Aralık
$3–$14
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$32
P/E
·
ROE
200.2%
Net Kâr Marjı
-20059.9%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
CLNN Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$4.08
Piyasa Değeri (MRQ)
$52M
Gelir
$200.0K
ROE
200.2%
52 Haftlık Aralık
$3–$14
CLNN Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 11 Temmuz 2024 | 1-for-20 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$200.0K2020-12-31 → 2025-12-31
Serbest Nakit Akışı$-19M2020-12-31 → 2025-12-31
Net kar marjı-20059.9%2020-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | CLNN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| F/S (TTM) | 264.65Y ort. ≈2370.1 | ≈2370.1 | 186.1 | Aşırı değerli | |
| F/D (MRQ) | -2.15Y ort. ≈183.3 | ≈183.3 | · | · | |
| Price / FCF (Fiyat / Serbest Nakit Akışı) | -2.45Y ort. ≈-41.3 | ≈-41.3 | · | · | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -2.45Y ort. ≈-43.4 | ≈-43.4 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 40.05Y ort. ≈308.4 | ≈308.4 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | CLNN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -10432.0%5Y ort. ≈-8912.7% | ≈-8912.7% | -4413.7% | Zayıf | |
| EBITDA Margin (FAVÖK Marjı) | -11541.5%5Y ort. ≈-8912.7% | ≈-8912.7% | -4413.7% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | -20059.9%5Y ort. ≈-7981.6% | ≈-7981.6% | · | · | |
| Net Kâr Marjı (TTM) | -20059.9%5Y ort. ≈-7969.7% | ≈-7969.7% | -4292.0% | Zayıf | |
| ROA | -115.1%5Y ort. ≈-77.4% | ≈-77.4% | -82.2% | Zayıf | |
| ROE | 200.2%5Y ort. ≈280.0% | ≈280.0% | -72.9% | En üst düzey | |
| ROIC | 131.2%5Y ort. ≈-101.1% | ≈-101.1% | -76.7% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | CLNN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 3.15Y ort. ≈3.0 | ≈3.0 | 3.9 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 0.55Y ort. ≈2.6 | ≈2.6 | 2.5 | Ortalamanın altında |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | CLNN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -41.5%5Y ort. ≈33.1% | ≈33.1% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -24.9%5Y ort. ≈-0.02% | ≈-0.02% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | -0.59% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | CLNN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.05Y ort. ≈0.0 | ≈0.0 | 0.0 | Ortalamanın altında | |
| Inventory Turnover (Stok Devir Hızı) | 0.85Y ort. ≈1.4 | ≈1.4 | · | · | |
| Receivables Turnover (Alacak Devir Hızı) | 6.25Y ort. ≈7.6 | ≈7.6 | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$2.6K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-31.8%
Sonraki Rapor
Kas 11, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 14, 2026 | $-1.08 | $-0.38 | -187.7% |
| 31 Mart 2026 | May 14, 2026 | $-0.27 | $-0.65 | 58.4% |
| 31 Aralık 2025 | $-0.88 | $-0.60 | -47.2% | |
| 30 Eylül 2025 | $-0.85 | $-0.59 | -43.7% | |
| 30 Haziran 2025 | $-0.78 | $-0.48 | -61.6% | |
| 31 Mart 2025 | $-0.09 | $-0.97 | 90.7% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $200.0K | $342.0K | $654.0K | $473.0K | $723.0K | $206.0K | |
| Cost of Revenue | $43.0K | $70.0K | $121.0K | $26.0K | $289.0K | · | |
| R&D Expense | $14M | $20M | $27M | $32M | $28M | $15M | |
| SG&A Expense | $9M | $13M | $14M | $17M | $22M | $5M | |
| Operating Expenses | $23M | $33M | $41M | $49M | $51M | $20M | |
| Operating Income | $-23M | $-33M | $-41M | $-48M | $-50M | $-20M | |
| Interest Expense | · | · | $5M | $3M | $870.0K | $950.0K | |
| Interest Income | $223.0K | $865.0K | $1M | $225.0K | · | · | |
| Other Non-op | $0 | $-1.0K | $10.0K | $32.0K | $-12.0K | $34.0K | |
| Pretax Income | $-26M | $-39M | $-50M | $-30M | $-10M | $-19M | |
| Income Tax | $0 | $0 | $0 | $0 | $-428.0K | $406.0K | |
| Net Income | $-26M | $-39M | $-50M | $-30M | $-10M | $-19M | |
| EPS (Basic) | $-2.65 | $-5.67 | $-9.43 | $-0.46 | $-0.16 | · | |
| Shares (Basic) | 9,858,907 | 6,954,133 | 5,246,941 | 65,204,663 | 61,558,455 | · | |
| EBITDA | $-23M | $-33M | $-41M | $-48M | $-50M | $-20M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $12M | $29M | $18M | $50M | $59M | |
| Short-term Investments | · | $0 | $6M | $5M | $0 | · | |
| Receivables | $0 | $64.0K | $143.0K | $189.0K | $49.0K | $21.0K | |
| Inventory | $37.0K | $68.0K | $37.0K | $43.0K | $41.0K | $191.0K | |
| Prepaid Expense | $4M | $4M | $4M | $6M | $4M | $4M | |
| Other Current Assets | $425.0K | $137.0K | $568.0K | $581.0K | $404.0K | · | |
| Current Assets | $9M | $16M | $39M | $29M | $55M | $63M | |
| PP&E (Net) | · | · | · | · | $5M | $4M | |
| PP&E (Gross) | · | · | · | · | $9M | $8M | |
| Accum. Depreciation | · | · | · | · | $4M | $3M | |
| Total Assets | $18M | $27M | $52M | $44M | $63M | $68M | |
| Accounts Payable | $892.0K | $1M | $2M | $3M | $2M | $1M | |
| Accrued Liabilities | $5M | $8M | $4M | $4M | $4M | $4M | |
| Short-term Debt | · | $359.0K | $15M | $6M | $0 | · | |
| Current Liabilities | $11M | $10M | $25M | $14M | $6M | $12M | |
| Capital Leases | $3M | $4M | $5M | $6M | $4M | $2M | |
| Deferred Tax | · | · | · | · | $0 | $260.0K | |
| Total Liabilities | $36M | $36M | $39M | $41M | $50M | $68M | |
| Long-term Debt | $18M | · | · | · | · | · | |
| Total Debt | · | $359.0K | $15M | $6M | · | $6M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $7.0K | $6.0K | $6.0K | |
| Paid-in Capital | $291M | $273M | $256M | $196M | $176M | $154M | |
| Retained Earnings | $-308M | $-282M | $-243M | $-193M | $-163M | $-154M | |
| AOCI | $172.0K | $71.0K | $199.0K | $203.0K | $233.0K | $325.0K | |
| Stockholders' Equity | $-18M | $-9M | $13M | $3M | $13M | $341.0K | |
| Liabilities + Equity | $18M | $27M | $52M | $44M | $63M | $68M | |
| Shares Outstanding | 10,849,974 | 8,089,565 | 6,421,084 | 74,759,591 | 62,312,097 | 59,526,171 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $8M | $9M | $9M | $12M | $761.0K | |
| Deferred Tax | · | · | · | $0 | $-282.0K | $260.0K | |
| Operating Cash Flow | $-19M | $-21M | $-30M | $-39M | $-35M | $-19M | |
| CapEx | $39.0K | $15.0K | $330.0K | $5M | $1M | $387.0K | |
| Investing Cash Flow | $-39.0K | $6M | $-1M | $-10M | $-1M | $-387.0K | |
| Stock Issued | · | · | · | $11M | $0 | · | |
| Net Stock Activity | · | · | · | $11M | · | · | |
| Financing Cash Flow | $12M | $-2M | $42M | $17M | $27M | $70M | |
| Net Change in Cash | $-7M | $-17M | $10M | $-32M | $-9M | $50M | |
| Free Cash Flow | $-19M | $-21M | $-31M | $-44M | $-36M | $-19M | |
| Levered FCF | · | · | $-35M | · | $-37M | $-20M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -11541.5% | -9676.3% | -6198.8% | -10234.5% | -6912.6% | -9812.6% | |
| Net Margin | -13086.5% | -11520.5% | -7569.4% | -6325.2% | -1347.2% | -9357.8% | |
| Pretax Margin | -13086.5% | -11520.5% | -7569.4% | -6325.2% | -1406.4% | -9160.7% | |
| EBITDA Margin | -11541.5% | -9676.3% | -6198.8% | -10234.5% | -6912.6% | -9812.6% | |
| ROA | -115.1% | -98.9% | -102.2% | -55.6% | -14.8% | -46.4% | |
| ROE | 200.2% | 607.0% | -284.6% | 983.8% | -106.5% | 44.4% | |
| ROIC | 131.2% | 389.4% | -144.7% | -501.4% | -380.1% | -329.6% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.6 | 1.5 | 2.1 | 9.1 | 5.4 | |
| Quick Ratio | 0.5 | 1.2 | 1.4 | 1.7 | 8.4 | 5.1 | |
| Debt / Equity | · | -0.0 | 1.1 | 2.0 | · | 17.4 | |
| Interest Coverage | · | · | -8.9 | · | -57.4 | -21.3 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 0.8 | 1.3 | 3.0 | 0.6 | · | · | |
| Receivables Turnover | 6.2 | 3.3 | 3.9 | 4.0 | 20.7 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.62 | $-1.09 | $0.10 | $0.04 | $0.20 | $0.01 | |
| Cash / Share | $0.48 | $1.50 | $0.22 | $0.25 | $0.81 | $1.00 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -41.5% | -47.7% | 38.3% | -34.6% | 251.0% | · | |
| Revenue CAGR 3Y | -24.9% | -22.1% | 47.0% | · | · | · | |
| Revenue CAGR 5Y | -0.59% | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $200.0K | $342.0K | $654.0K | $473.0K | $723.0K | $206.0K | |
| Net Income TTM | $-26M | $-39M | $-50M | $-30M | $-10M | $-19M | |
| Market Cap | $64M | $43M | $771M | $1.50B | $5.11B | $12.88B | |
| Enterprise Value | · | $31M | $750M | $1.48B | · | $12.83B | |
| P/S | 318.4 | 125.6 | 1178.2 | 3161.1 | 7067.2 | 62531.4 | |
| P/B | -3.6 | -4.8 | 57.5 | 461.9 | 405.6 | 37775.6 | |
| P / Tangible Book | · | · | 57.5 | 461.9 | 405.6 | 37775.6 | |
| P / Cash Flow | -3.4 | -2.0 | -25.5 | -38.3 | -147.6 | -680.5 | |
| P / FCF | -3.4 | -2.0 | -25.3 | -33.8 | -142.1 | -666.9 | |
| EV / EBITDA | · | -0.9 | -18.5 | -30.5 | · | -634.6 | |
| EV / FCF | · | -1.5 | -24.6 | -33.5 | · | -664.1 | |
| EV / Revenue | · | 91.1 | 1147.0 | 3125.4 | · | 62272.4 |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $90.0K | $15.0K | $77.0K | $15.0K | $27.0K | $81.0K | $91.0K | $87.0K | $91.0K | $73.0K | $170.0K | $108.0K | $269.0K | $107.0K | $234.0K | $174.0K | |
| Cost of Revenue | $36.0K | $0 | $23.0K | $0 | $0 | $20.0K | $18.0K | $18.0K | $18.0K | $16.0K | $38.0K | $12.0K | $66.0K | $5.0K | $7.0K | $19.0K | |
| R&D Expense | $3M | $329.0K | $6M | $4M | $4M | $1M | $6M | $4M | $4M | $6M | $7M | $6M | $7M | $7M | $8M | $6M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $4M | $4M | |
| Operating Expenses | $5M | $2M | $8M | $6M | $6M | $4M | $9M | $8M | $7M | $9M | $10M | $10M | $11M | $11M | $12M | $10M | |
| Operating Income | $-5M | $-2M | $-7M | $-6M | $-6M | $-4M | $-9M | $-8M | $-7M | $-9M | $-10M | $-10M | $-10M | $-11M | $-12M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | $1M | $1M | $1M | $906.0K | $857.0K | |
| Interest Income | $55.0K | $47.0K | $40.0K | $40.0K | $62.0K | $81.0K | $110.0K | $127.0K | $269.0K | $359.0K | $458.0K | $546.0K | $213.0K | $172.0K | $81.0K | $59.0K | |
| Other Non-op | $-8M | $-6M | $1M | $-3M | $-2M | $3M | $1M | $-171.0K | $606.0K | $-2M | $-25.0K | $45.0K | $-13.0K | $3.0K | $-3.0K | $-72.0K | |
| Pretax Income | $-13M | $-8M | $-9M | $-9M | $-7M | $-751.0K | $-14M | $-8M | $-7M | $-11M | $-10M | $-2M | $-25M | $-12M | $-1M | $-11M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-13M | $-8M | $-9M | $-9M | $-7M | $-751.0K | $-14M | $-8M | $-7M | $-11M | $-10M | $-2M | $-25M | $-12M | $-1M | $-11M | |
| EPS (Basic) | $-1.08 | $-0.69 | $-0.93 | $-0.85 | $-0.78 | $-0.09 | $-1.66 | $-1.22 | $-1.06 | $-1.73 | $-3.06 | $-0.38 | $-5.84 | $-0.15 | $-0.01 | $-0.17 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.17 | |
| Shares (Basic) | 12,382,702 | 11,644,214 | · | 10,284,674 | 9,523,592 | 8,824,673 | · | 6,557,839 | 6,423,182 | 6,421,362 | · | 6,420,274 | 4,302,520 | 76,049,665 | · | 63,508,928 | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 63,508,928 | |
| EBITDA | $-5M | $-2M | · | $-6M | $-6M | $-4M | · | $-8M | $-7M | $-9M | · | $-10M | $-10M | $-11M | · | $-10M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $6M | $5M | $8M | $7M | $10M | $12M | $15M | $22M | $22M | $29M | $42M | $49M | $18M | $18M | $7M | |
| Short-term Investments | · | · | · | · | · | · | · | $0 | $0 | $6M | $6M | $0 | $0 | $0 | $5M | $9M | |
| Receivables | $43.0K | · | $0 | $0 | $0 | $0 | $64.0K | $0 | $0 | $64.0K | $143.0K | $64.0K | $161.0K | $63.0K | $189.0K | $126.0K | |
| Inventory | $37.0K | $54.0K | $37.0K | $61.0K | $79.0K | $38.0K | $68.0K | $128.0K | $37.0K | $37.0K | $37.0K | $104.0K | $52.0K | $88.0K | $43.0K | $38.0K | |
| Prepaid Expense | $5M | $7M | $4M | $5M | $5M | $5M | $4M | $5M | $6M | $4M | $4M | $4M | $4M | $6M | $6M | $5M | |
| Other Current Assets | $211.0K | $244.0K | $139.0K | $302.0K | $358.0K | $346.0K | $137.0K | $777.0K | $911.0K | $832.0K | $568.0K | $1M | $883.0K | $962.0K | $581.0K | · | |
| Current Assets | $15M | $13M | $9M | $13M | $12M | $15M | $16M | $20M | $28M | $32M | $39M | $46M | $53M | $25M | $29M | $21M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $10M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $15M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Total Assets | $23M | $22M | $18M | $22M | $22M | $25M | $27M | $32M | $40M | $45M | $52M | $60M | $68M | $40M | $44M | $36M | |
| Accounts Payable | $1M | $1M | $892.0K | $1M | $828.0K | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $846.0K | $608.0K | $3M | $3M | |
| Accrued Liabilities | $2M | $3M | $5M | $5M | $5M | $5M | $8M | $7M | $6M | $4M | $4M | $3M | $4M | $6M | $4M | $2M | |
| Short-term Debt | · | · | · | · | · | $3M | · | $11M | $20M | $15M | $15M | $10M | $0 | $10M | $6M | · | |
| Current Liabilities | $5M | $7M | $11M | $8M | $8M | $11M | $10M | $24M | $28M | $26M | $25M | $15M | $6M | $17M | $14M | $6M | |
| Capital Leases | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | |
| Total Liabilities | $48M | $40M | $36M | $35M | $31M | $30M | $36M | $36M | $41M | $41M | $39M | $39M | $46M | $42M | $41M | $45M | |
| Long-term Debt | $18M | $18M | $18M | $18M | $16M | $17M | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | · | · | $3M | · | $11M | $20M | $15M | · | $10M | $0 | $10M | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $13.0K | $1.0K | $13.0K | $13.0K | $8.0K | $7.0K | $6.0K | |
| Paid-in Capital | $305M | $297M | $291M | $287M | $282M | $278M | $273M | $264M | $260M | $258M | $256M | $254M | $251M | $203M | $196M | $183M | |
| Retained Earnings | $-330M | $-316M | $-308M | $-299M | $-290M | $-283M | $-282M | $-269M | $-261M | $-254M | $-243M | $-233M | $-230M | $-205M | $-193M | $-192M | |
| AOCI | $208.0K | $216.0K | $172.0K | $150.0K | $149.0K | $86.0K | $71.0K | $223.0K | $170.0K | $140.0K | $199.0K | $89.0K | $174.0K | $221.0K | $203.0K | $80.0K | |
| Stockholders' Equity | $-25M | $-19M | $-18M | $-12M | $-9M | $-5M | $-9M | $-4M | $-504.0K | $4M | $13M | $21M | $22M | $-2M | $3M | $-9M | |
| Liabilities + Equity | $23M | $22M | $18M | $22M | $22M | $25M | $27M | $32M | $40M | $45M | $52M | $60M | $68M | $40M | $44M | $36M | |
| Shares Outstanding | 12,778,307 | 11,778,307 | 10,849,974 | 10,219,946 | 9,462,071 | 8,667,770 | 8,089,565 | 6,857,170 | 6,433,628 | 128,433,721 | 6,421,084 | 128,411,981 | 128,401,112 | 77,987,349 | 74,759,591 | 63,541,984 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-3M | $-5M | $-5M | $-4M | $-5M | $-5M | $-5M | $-3M | $-6M | $-7M | $-7M | $-7M | $-7M | $-9M | $-8M | $-8M | |
| CapEx | · | · | $28.0K | $11.0K | $0 | $0 | $1.0K | $1.0K | $2.0K | $11.0K | $43.0K | $48.0K | $-39.0K | $278.0K | $2M | $2M | |
| Investing Cash Flow | $-1.0K | $0 | $-28.0K | $-11.0K | $0 | $0 | $-2.0K | $-1.0K | $6M | $71.0K | $-6M | $-48.0K | $39.0K | $5M | $2M | $8M | |
| Stock Issued | · | · | · | $3M | $2M | $3M | · | $2M | $0 | $0 | · | · | $37M | $4M | · | · | |
| Net Stock Activity | · | · | · | · | · | $3M | · | · | · | · | · | · | $37M | $4M | · | · | |
| Financing Cash Flow | $6M | $5M | $2M | $5M | $2M | $3M | $3M | $-4M | $28.0K | $-19.0K | $-18.0K | $-237.0K | $38M | $5M | $16M | $92.0K | |
| Net Change in Cash | $4M | $750.0K | $-3M | $640.0K | $-3M | $-2M | $-2M | $-7M | $-50.0K | $-7M | $-13M | $-7M | $31M | $110.0K | $11M | $14.0K | |
| Free Cash Flow | · | · | · | · | · | $-5M | · | · | · | $-7M | · | · | · | $-9M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-8M | · | · | · | $-11M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5941.1% | -13740.0% | · | -37653.3% | -21718.5% | -5032.1% | · | -8982.8% | -8122.0% | -12646.6% | · | -8835.2% | -3842.4% | -10029.9% | · | -5635.1% | |
| Net Margin | -14915.6% | -53940.0% | · | -58513.3% | -27477.8% | -927.2% | · | -9179.3% | -7456.0% | -15178.1% | · | -2238.9% | -9346.8% | -11000.0% | · | -6308.1% | |
| Pretax Margin | -14915.6% | -53940.0% | · | -58513.3% | -27477.8% | -927.2% | · | -9179.3% | -7456.0% | -15178.1% | · | -2238.9% | -9346.8% | -11000.0% | · | -6308.1% | |
| EBITDA Margin | -5941.1% | -13740.0% | · | -37653.3% | -21718.5% | -5032.1% | · | -8982.8% | -8122.0% | -12646.6% | · | -8835.2% | -3842.4% | -10029.9% | · | -5635.1% | |
| ROA | -59.4% | -34.4% | · | -32.6% | -23.8% | -2.1% | · | -17.4% | -12.5% | -26.1% | · | -5.0% | -44.7% | -25.2% | · | -20.1% | |
| ROE | 80.6% | 68.0% | · | 106.5% | 163.9% | 211.8% | · | -92.4% | -64.5% | -840.3% | · | -40.0% | -239.8% | -6035.9% | · | 604.2% | |
| ROIC | 21.6% | 11.0% | · | 45.7% | 68.6% | 220.1% | · | -115.8% | -37.0% | -48.0% | · | -30.8% | -48.0% | -132.1% | · | 105.2% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | 1.9 | · | 1.5 | 1.6 | 1.4 | · | 0.8 | 1.0 | 1.2 | · | 3.0 | 9.3 | 1.5 | · | 3.5 | |
| Quick Ratio | 2.0 | 0.9 | · | 1.0 | 1.0 | 0.9 | · | 0.6 | 0.8 | 1.1 | · | 2.8 | 8.6 | 1.1 | · | 2.7 | |
| Debt / Equity | · | · | · | · | · | -0.6 | · | -2.6 | -40.6 | 3.5 | · | 0.4 | 0.0 | -6.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -7.4 | · | -8.0 | -9.4 | -10.1 | · | · |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.6 | 0.0 | · | 0.0 | 0.0 | 0.5 | · | 0.2 | 0.4 | 0.3 | · | 0.2 | 0.8 | 0.1 | · | · | |
| Receivables Turnover | 4.2 | · | · | · | · | 2.5 | · | 2.7 | 1.1 | 1.1 | · | 1.1 | 3.3 | 3.4 | · | 1.8 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.94 | $-1.60 | · | $-1.21 | $-0.90 | $-0.57 | · | $-0.60 | $-0.08 | $0.03 | · | $0.17 | $0.17 | $-0.02 | · | $-0.15 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.00 | |
| Cash / Share | $0.76 | $0.50 | · | $0.78 | $0.77 | $1.13 | · | $2.14 | $3.37 | $0.17 | · | $0.33 | $0.38 | $0.24 | · | $0.11 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $197.0K | $134.0K | · | $214.0K | $286.0K | $350.0K | · | $421.0K | $442.0K | $620.0K | · | $718.0K | $784.0K | $550.0K | · | $438.0K | |
| Net Income TTM | $-40M | $-34M | · | $-30M | $-30M | $-29M | · | $-36M | $-30M | $-49M | · | $-40M | $-49M | $-28M | · | $-24M | |
| Market Cap | $79M | $58M | · | $62M | $37M | $27M | · | $31M | $46M | $1.10B | · | $1.28B | $2.26B | $1.76B | · | $3.56B | |
| Enterprise Value | · | · | · | · | · | $20M | · | $28M | $45M | $1.09B | · | $1.25B | $2.21B | $1.75B | · | · | |
| P/S | 399.6 | 433.3 | · | 288.0 | 129.4 | 76.3 | · | 74.8 | 104.8 | 1781.5 | · | 1788.5 | 2882.5 | 3204.6 | · | 8124.1 | |
| P/B | -3.2 | -3.1 | · | -5.0 | -4.3 | -5.4 | · | -7.6 | -91.9 | 259.0 | · | 60.0 | 104.9 | -1083.3 | · | -381.8 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | 259.0 | · | 60.0 | 104.9 | · | · | · | |
| P / Cash Flow | · | -12.8 | · | · | · | -5.3 | · | · | · | -156.0 | · | · | · | -191.2 | · | · | |
| EV / Revenue | · | · | · | · | · | 57.1 | · | 65.8 | 102.0 | 1760.7 | · | 1743.2 | 2819.7 | 3188.8 | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $200.0K | $342.0K | $654.0K | $473.0K | $723.0K |
| Faaliyet Kâr Marjı % | -11541.5% | -9676.3% | -6198.8% | -10234.5% | -6912.6% |
| Net Gelir | $-26M | $-39M | $-50M | $-30M | $-10M |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | -0.0 | 1.1 | 2.0 | · |
| Cari Oran | 0.8 | 1.6 | 1.5 | 2.1 | 9.1 |
| Cari Oran | 0.5 | 1.2 | 1.4 | 1.7 | 8.4 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-19M | $-21M | $-31M | $-44M | $-36M |
Kurumsal Sahipler (13F) 37 dosya · $22.9M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
37
Tutulan Değer
$22.9M
Yeni pozisyonlar
7
Çıkan pozisyonlar
2
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 7 (+3 önceki Ç'ye göre) | 2 (0 önceki Ç'ye göre) | 10 (+5 önceki Ç'ye göre) | 4 (+1 önceki Ç'ye göre) | +988K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Empery Asset Management, LP | $5.641.254 | 916.532 | 24,63% | Hisse senetleri |
| SCOGGIN MANAGEMENT LP | $3.693.000 | 600.000 | 16,12% | Hisse senetleri |
| Boxer Capital Management, LLC | $2.939.105 | 477.515 | 12,83% | Hisse senetleri |
| Ensign Peak Advisors, Inc | $2.142.322 | 348.062 | 9,35% | Hisse senetleri |
| SymBiosis Capital Partners, LLC | $2.125.293 | 431.094 | 9,28% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.053.960 | 333.706 | 8,97% | Hisse senetleri |
| VANGUARD GROUP INC | $1.308.476 | 222.909 | 5,71% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $629.645 | 102.215 | 2,75% | Hisse senetleri |
| BlackRock, Inc. | $378.895 | 61.559 | 1,65% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $355.544 | 57.765 | 1,55% | Hisse senetleri |
| Lunt Capital Management, Inc. | $321.660 | 52.260 | 1,40% | Hisse senetleri |
| PARSONS CAPITAL MANAGEMENT INC/RI | $229.231 | 37.243 | 1,00% | Hisse senetleri |
| PEAK6 LLC | $184.724 | 30.012 | 0,81% | Hisse senetleri |
| STATE STREET CORP | $183.425 | 29.801 | 0,80% | Hisse senetleri |
| MORGAN STANLEY | $122.226 | 19.858 | 0,53% | Hisse senetleri |
| NORTHERN TRUST CORP | $121.395 | 19.723 | 0,53% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $92.325 | 15.000 | 0,40% | Hisse senetleri |
| Arax Advisory Partners | $68.567 | 11.140 | 0,30% | Hisse senetleri |
| PENN DAVIS MCFARLAND INC | $67.705 | 11.000 | 0,30% | Hisse senetleri |
| JANE STREET GROUP, LLC | $62.799 | 10.203 | 0,27% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $36.481 | 5.927 | 0,16% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $34.523 | 5.609 | 0,15% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $30.300 | 5.000 | 0,13% | Hisse senetleri |
| ROYAL BANK OF CANADA | $18.000 | 3.000 | 0,08% | Hisse senetleri |
| PNC Financial Services Group, Inc. | $16.834 | 2.735 | 0,07% | Hisse senetleri |
| Atlantic Private Wealth, LLC | $13.572 | 2.205 | 0,06% | Hisse senetleri |
| Steward Partners Investment Advisory, LLC | $12.310 | 2.000 | 0,05% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $6.493 | 1.055 | 0,03% | Hisse senetleri |
| SBI Securities Co., Ltd. | $6.309 | 1.025 | 0,03% | Hisse senetleri |
| GROUP ONE TRADING LLC | $4.222 | 686 | 0,02% | Hisse senetleri |
| Sandy Spring Bank | $3.080 | 1.000 | 0,01% | Hisse senetleri |
| UBS Group AG | $2.161 | 351 | 0,01% | Hisse senetleri |
| BARCLAYS PLC | $1.397 | 227 | 0,01% | Hisse senetleri |
| Lindbrook Capital, LLC | $308 | 100 | 0,00% | Hisse senetleri |
| US BANCORP \DE\ | $123 | 20 | 0,00% | Hisse senetleri |
| HRT FINANCIAL LP | $112 | 18.321 | 0,00% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $80 | 13 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 3 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| David J. Matlin ×5 başvurular | 02 Ekim 2024 | · | İlk başvuru | Pasif yatırım | SEC |
| Chidozie Ugwumba ×2 başvurular | 13 Şubat 2023 | · | İlk başvuru | Pasif yatırım | SEC |
| Açıklanmayan raporlama kişisi | 11 Ocak 2021 | · | İlk başvuru | M&A / satış | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 17 içeriden öğrenenler · 5 yöneticiler · 11 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Robert Dee Etherington | President & CEO | 16 Eylül 2026 A | 55.393 | 0 | 0 | $0 |
| Morgan R Brown | Chief Financial Officer | 11 Haziran 2026 A | · | 0 | 0 | $0 |
| Mark Mortenson | Chief Science Officer | 11 Haziran 2026 A | 28.949 | 0 | 0 | $0 |
| Robert Glanzman | Chief Medical Officer | 16 Mayıs 2022 S | 10.564 | 0 | 0 | $0 |
| Tae Heum Jeong | Chief Finance Officer | 04 Kasım 2021 A | · | 0 | 0 | $0 |
| Alison Mosca | Yönetim kurulu üyesi | 16 Eylül 2026 A | 478.671 | 0 | 0 | $0 |
| David J Matlin | Yönetim kurulu üyesi | 16 Eylül 2026 A | 912.275 | 1 | 0 | $216.664 |
| Matthew Kiernan | Yönetim kurulu üyesi | 13 Ağustos 2026 A | · | 0 | 0 | $0 |
| Arjun Jj Desai | Yönetim kurulu üyesi | 13 Ağustos 2026 A | · | 0 | 0 | $0 |
| Vallerie Mclaughlin | Yönetim kurulu üyesi | 13 Ağustos 2026 A | · | 0 | 0 | $0 |
| Shalom Jacobovitz | Yönetim kurulu üyesi | 13 Ağustos 2026 A | 20.838 | 0 | 0 | $0 |
| Jonathon Gay | Yönetim kurulu üyesi | 13 Ağustos 2026 A | 105.625 | 0 | 0 | $0 |
| Reed N Wilcox | Yönetim kurulu üyesi | 13 Ağustos 2026 A | 575.145 | 0 | 0 | $0 |
| John Henry Stevens | Yönetim kurulu üyesi | 18 Eylül 2023 A | 800.204 | 0 | 0 | $0 |
| Fiona Costello | Yönetim kurulu üyesi | 18 Mayıs 2021 A | · | 0 | 0 | $0 |
| Chidozie Ugwumba | 10% sahip | 17 Temmuz 2026 J | 103.417 | 0 | 62 | $-5.781.158 |
| General Resonance LLC | 10% sahip | 21 Ağustos 2025 S | 704.591 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 3 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
CLNN Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 11 analist
AL
Medyan hedef
$30.00
+635,3%
2 18,2%
Güçlü Al
8 72,7%
Al
1 9,1%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
5 analist · 2026-09-29Ortalama hedef $32.20 +689,2%
← Tüm hedeflerin altında
Mevcut fiyat $4.08
Düşük$20.00
Ortalama$32.20
Yüksek$50.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| CLNN | $64M | · | -41.5% | -13086.5% | 200.2% | · |
| FRMM | · | · | · | -6881.3% | -368.1% | · |
| INKT | · | -3.8 | 4.5% | -6931.8% | 63.4% | · |
| ACET | · | -0.5 | · | · | · | · |
| CNTB | $159M | -2.8 | -99.8% | -86687.5% | -97.9% | · |
| BOLD | $27M | -0.5 | · | · | -46.7% | · |
| KLRS | $193M | -3.0 | · | · | -65.8% | · |
| INMB | $41M | -0.8 | 257.1% | -91866.0% | -175.3% | · |
| XLO | $3M | -0.2 | 589.9% | -80.0% | -165.5% | · |
| EXOZ | $92M | -10.0 | · | · | -172.3% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 14, 2026